Order results by:
Issue | Title | |
Vol 12, No 1 (2019) | Prevalence survey of musculoskeletal and connective tissue disorders in the Russian Federation | Abstract similar documents |
T. A. Oleynikova, D. N. Pozhidaeva, A. Yu. Oreshko | ||
"... Diseases of the musculoskeletal system and connective tissues are becoming more and more common ..." | ||
Vol 9, No 2 (2016) | PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION | Abstract similar documents |
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva | ||
"... in particular of providing preferential medicines patients with сhronic obstructive pulmonary disease (COPD ..." | ||
Vol 14, No 4 (2021) | Economic burden of chronic viral hepatitis C | Abstract similar documents |
R. A. Yakhina, I. A. Lakman, D. A. Valishin, R. Kh. Bakhitova | ||
"... of patients. Therefore, an important task remains to assess the global economic burden of the disease, taking ..." | ||
Vol 11, No 4 (2018) | Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease | Abstract similar documents |
V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev | ||
"... Fabry disease (FD) is a severe lysosome storage disease caused by congenital deficiency ..." | ||
Vol 10, No 1 (2017) | CLINICAL AND ECONOMIC EVALUATION OF ERIBULIN EFFECTIVENESS IN SOFT TISSUE SARCOMA: RESULTS OF META-ANALYSIS | Abstract similar documents |
P. V. Мazin, I. V. Sheshunov, N. K. Mazina, E. M. Markova | ||
"... Innovative drugs eribulin and trabectedin are effective in the treatment of soft tissue sarcomas ..." | ||
Vol 7, No 2 (2014) | ECONOMIC ANALYSIS OF USE OF IMMUNOCORRECTIVE PREPARATIONS FOR PREVENTION OF OFTEN RESPIRATORY INFECTIONS AND THEIR COMPLICATIONS AT CHILDREN OF SCHOOL AGE | Abstract similar documents |
R. V. Maiorov, D. P. Derbenev | ||
"... infections and considerable decrease direct and indirect cost on treatment of respiratory infectious diseases ..." | ||
Vol 13, No 4 (2020) | The social-economic burden of spinal muscular atrophy in Russia | Abstract similar documents |
A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina | ||
"... congenital orphan diseases that lead to progressive spinal motoneurons degeneration and loss ..." | ||
Vol 13, No 3 (2020) | Economic burden of systemic sclerosis: systematic review | Abstract similar documents |
D. L. Klabukova, V. S. Krysanova, T. N. Ermolaeva, M. V. Davydovskaya, K. A. Kokushkin | ||
"... of connective tissue. This disease has a significant negative impact on the patient’s quality of life and has ..." | ||
Vol 14, No 3 (2021) | Increasing the medico-economic efficiency of preventive counseling for patients with arterial hypertension and behavioral risk factors for non-communicable diseases | Abstract similar documents |
O. L. Zadvornaya, A. N. Pishchita | ||
"... -economic efficiency of the prevention of cardiovascular diseases (CVDs). Material and methods. A total ..." | ||
Vol 14, No 3 (2021) | An economic evaluation of pre-dialysis stage of chronic kidney disease | Abstract similar documents |
E. I. Rumiantseva, M. V. Avxentyeva | ||
"... disease (CKD) and the cost-effectiveness of medical interventions used to detect CKD and prevent its ..." | ||
Vol 17, No 4 (2024) | Pharmacoeconomic study of active psoriatic arthritis treatment | Abstract similar documents |
A. V. Rudakova, Т. V. Korotaeva | ||
"... biological (b) and targeted synthetic (ts) disease-modifying antirheumatic drugs (DMARDs), available ..." | ||
Vol 18, No 1 (2025) | Analysis of methotrexate use practice in patients with rheumatoid and psoriatic arthritis | Abstract similar documents |
S. A. Doktorova, Yu. Yu. Grabovetskaya, A. V. Zuev, J. N. Aksenova-Sorokhtei, V. V. Rafalskiy | ||
"... for various diseases. In particular, significant progress in the treatment of rheumatoid arthritis (RA ..." | ||
Vol 5, No 1 (2012) | EСOLOGO-ECONOMIC PROBLEMS OF TECHNOGENIC INFLUENCE OF POLLUTION ON DISEASE OF THE POPULATION | Abstract similar documents |
A. I. Borodin, E. M. Ovchinnikov | ||
Vol 7, No 3 (2014) | ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION | Abstract similar documents |
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
"... with orphan diseases, included in the list of orphan diseases (24 diseases) by the RF Government Regulation ..." | ||
Vol 7, No 4 (2014) | APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES | Abstract similar documents |
V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova | ||
"... financing of rare disease drugs remains a serious problem for both foreign countries and our ..." | ||
Vol 8, No 1 (2015) | PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE | Abstract similar documents |
D. V. Blinov, U. V. Zimovina, T. I. Ushakova | ||
"... Chronic liver diseases are a serious problem and a common cause of suffering and death in all ..." | ||
Vol 8, No 2 (2015) | REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS | Abstract similar documents |
Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev | ||
"... Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal ..." | ||
Vol 11, No 4 (2018) | Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions | Abstract similar documents |
G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina | ||
"... The aim is to analyze the medical records of patients with malignant lymphoproliferative diseases ..." | ||
Vol 13, No 4 (2020) | Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm | Abstract similar documents |
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov | ||
Vol 14, No 3 (2021) | Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines | Abstract similar documents |
I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva | ||
"... diseases and to identify the main trends in the implementation of the federal program for the provision ..." | ||
Vol 14, No 3 (2021) | Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital | Abstract similar documents |
L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva | ||
"... drugs included in the standards of pharmacotherapy for rheumatic diseases. According to VEN analysis all ..." | ||
Vol 16, No 4 (2023) | Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen | Abstract similar documents |
I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova | ||
"... publications on the relationship between CS/GS/UC-II and tumor diseases found by the query “(glucosamine ..." | ||
Vol 16, No 4 (2023) | Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development | Abstract PDF (Eng) similar documents |
V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan | ||
"... for the local treatment of infectious and inflammatory diseases of oral cavity and oropharynx. Material ..." | ||
Vol 16, No 4 (2023) | DMOADs and DMARDs in the treatment of patients with joint and spine diseases | Abstract PDF (Eng) similar documents |
O. A. Shavlovskaya | ||
"... with joint and spine diseases, such as osteoarthritis (OA) and rheumatoid arthritis (RA), are presented ..." | ||
Vol 5, No 3 (2012) | PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
A. U. Kulikov, I. A. Komarov | ||
"... Currently, chronic obstructive pulmonary disease (COPD) is a 5-largest cause of death worldwide ..." | ||
Vol 7, No 4 (2014) | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY | Abstract similar documents |
D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky | ||
"... diseases. The analysis was conducted on the basis of 1499 selected trade procedures on rare disease drugs ..." | ||
Vol 8, No 3 (2015) | NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL | Abstract similar documents |
D. V. Blinov | ||
"... Introduction. Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important ..." | ||
Vol 9, No 2 (2016) | EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2 | Abstract similar documents |
V. V. Tsukanov, A. S. Yurkina, T. A. Ushakova, D. V. Blinov | ||
"... Non-alcoholic fatty liver disease (NAFLD) is an important medical and social problem. Essentially ..." | ||
Vol 9, No 2 (2016) | PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS | Abstract similar documents |
E. E. Vidyakina, S. V. Malchikova | ||
"... Objective. To determine the priority used to vital drugs in сhronic obstructive pulmonary disease ..." | ||
Vol 9, No 4 (2016) | PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY) | Abstract similar documents |
D. Kh. Kalimullina, A. S. Yurkina, T. I. Ushakova, D. V. Blinov | ||
"... Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important problem ..." | ||
Vol 10, No 1 (2017) | BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS | Abstract similar documents |
E. A. Pyadushkina | ||
"... ) and moderate or severe active Crohn’s disease (CT) with an unsatisfactory response, loss of response ..." | ||
Vol 12, No 1 (2019) | Economic consequences of healthcare optimization for IBD patients in the Republic of Tatarstan | Abstract similar documents |
T. P. Bezdenezhnykh, D. V. Fedyaev, G. R. Khachatryan, G. G. Arutyunov, K. V. Gerasimova | ||
"... The integrated Model of health care for patients with inflammatory bowel disease (IBD) is based ..." | ||
Vol 15, No 3 (2022) | Economic burden of the novel coronavirus infection: a systematic review | Abstract similar documents |
V. M. Timiryanova, I. A. Lakman, N. Sh. Zagidullin, D. F. Gareeva | ||
Online First | Osteoarthritis therapy misconcepts | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
"... Osteoarthritis (OA) is a painful and disabling disease affecting millions of people worldwide. OA ..." | ||
Vol 15, No 4 (2022) | Antibiotic resistance of uropathogens in patients with nephrolithiasis and concomitant coronary heart disease | Abstract similar documents |
R. V. Royuk, S. K. Yarovoy, I. B. Shikina | ||
"... their antibiotic resistance in patients with nephrolithiasis combined with coronary heart disease (CHD). Material ..." | ||
Vol 14, No 4 (2021) | Features of intellectual property protection mechanisms on the example of orphan drugs circulation | Abstract similar documents |
D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin | ||
"... of drugs for the treatment of rare (orphan) diseases. Material and methods. Analysis of pharmaceutical ..." | ||
Vol 14, No 4 (2021) | Prospects of using chondroprotectors for the treatment of pulmonary pathology | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin | ||
"... in lung function. CS and GS can be used in the complex therapy of infectious diseases of the lungs ..." | ||
Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
"... Osteoarthritis (OA) is a painful and disabling disease that affects millions of people around ..." | ||
Vol 16, No 2 (2023) | Molecular pharmacology of coenzyme Q10 in the context of treatment of hyperlipidemic conditions | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin | ||
"... neurological diseases. CoQ10 supplements reduce mortality by 50% in patients with cardiovascular diseases ..." | ||
Vol 16, No 3 (2023) | Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
"... The review examines pharmacological agents that can have potential disease-modifying ..." | ||
Vol 16, No 3 (2023) | Clinical and economic assessment of feasibility of using quadritherapy in patients with reduced ejection fraction chronic heart failure in medical organizations of the Moscow Region | Abstract similar documents |
A. D. Ermolaeva, T. N. Ermolaeva, K. A. Kokushkin | ||
"... circulatory diseases within the framework of the regional program “Health care development”. In order ..." | ||
Vol 16, No 3 (2023) | An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis | Abstract similar documents |
M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova | ||
"... ® in the treatment of nonalcoholic fatty liver disease (NAFLD) in a clinical trial. Material and methods. The study ..." | ||
Vol 16, No 3 (2023) | Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, A. N. Gromov | ||
"... effects. CoQ10 favorably affects carbohydrate metabolism and a wide range of neurological diseases ..." | ||
Vol 17, No 1 (2024) | Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov | ||
"... Background. The study of drug availability for patients with chronic obstructive pulmonary disease ..." | ||
Vol 17, No 4 (2024) | Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system | Abstract similar documents |
A. V. Rudakova, I. Z. Gaydukova | ||
"... spondylitis (AS) in comparison with other biological disease-modifying antirheumatic drugs (bDMARDs) currently ..." | ||
Online First | Comprehensive analysis of the relationships between somatometric, biochemical and clinical indicators of the condition of patients with chronic kidney diseases | Abstract similar documents |
I. Yu. Torshin, N. Z. Bashun, O. A. Gromova, A. V. Chekel, A. A. Levchuk, S. N. Lazarevich | ||
"... disease (CKD). Material and methods. The values of 58 parameters describing the condition of 357 ..." | ||
Vol 18, No 1 (2025) | Clinical and diagnostic significance of isolated detection of IgA antibodies to deamidated gliadin peptides in IgA nephropathy patients | Abstract similar documents |
M. E. Mantsaeva, D. I. Korabelnikov, A. G. Borisov | ||
"... of intestinal mucosa-associated lymphoid tissue (MALT) in IgAN pathogenesis, especially under the effect of food ..." | ||
Vol 10, No 1 (2017) | THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT | Abstract similar documents |
V. A. Nevzorova, M. V. Mokshina, T. A. Brodskaya, D. A. Vasil’chenkov, D. V. Blinov, T. I. Ushakova | ||
"... , stimulates medical experts to closely study the epidemiology of non-alcoholic fatty liver disease (NAFLD ..." | ||
Vol 13, No 3 (2020) | The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups | Abstract similar documents |
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan | ||
"... diagnosis-related group in terms of bronchial asthma (BA) and inflammatory bowel disease (IBD) - Crohn ..." | ||
1 - 50 of 59 Items | 1 2 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)